Eltek (ELTK) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue reached $13.5 million, a 14% increase year-over-year, with defense sector sales comprising 64%, industrial 14%, and medical 7%.

• Net income for Q3 2024 was $1.7 million ($0.25 per share), down from $2.1 million ($0.36 per share) in Q3 2023.

• Cash and cash equivalents stood at $18.1 million as of September 30, 2024, supporting ongoing growth initiatives.

• A new 15,000 sq. ft. manufacturing space with advanced Solder Mask Application line is set to open by year-end 2024.

• The Board adopted a dividend policy allowing annual distribution of up to 25% of net profit starting from 2024 year-end.

Financial highlights

• Q3 2024 gross profit was $3.5 million (26% margin), down from $3.7 million (31%) in Q3 2023 due to less favorable product mix and increased labor costs.

• Q3 2024 operating profit was $1.9 million, down from $2.3 million year-over-year.

• Q3 2024 EBITDA was $2.3 million (17% margin), compared to $2.6 million (22%) in Q3 2023.

• First nine months 2024 revenues were $35.8 million, up from $34.4 million in the same period last year.

• Positive operating cash flow of $1.6 million in Q3, down from $3.6 million in Q3 2023, mainly due to higher trade receivables.

Outlook and guidance

• Management expects continued robust demand in defense and medical sectors, with industrial segment anticipated to recover in 2025.

• Gross margin forecasted at 26%-29% in the medium to long term, reflecting wage and price adjustments.

• Production capacity expected to support $55-$65 million in sales by the end of the accelerated investment program.

• Dividend policy to distribute up to 25% of net income annually, effective from 2024 year-end.